{
  "abstract": "Cold tumors are poorly recognized by host immunity. Tumor tagging strategies—neoantigen, xenogeneic, and viral antigen tagging—endow tumor cells with identifiable antigens via engineered probiotics, oncolytic viruses, and mRNA delivery. These tactics yield compelling preclinical and clinical results, emerging as a novel promising strategy for cancer immunotherapy.",
  "abstract_shown": true,
  "affiliations": [
    "College of Animal Science and Technology, Zhongkai University of Agriculture and Engineering, Guangdong Engineering Technology Research Center of Biosafety and Intelligent Control for Aquatic Animals Diseases",
    "State Key Laboratory of Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences",
    "Guangdong Hengqin Newcastle disease virus (NDV) Biotechnology Co., Ltd."
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 4,
  "authors": [
    {
      "affs": [
        0,
        1
      ],
      "name": "Tong-Yun Wang"
    },
    {
      "affs": [
        1
      ],
      "name": "Yue Sun"
    },
    {
      "affs": [
        0,
        1,
        2
      ],
      "name": "Feng Cong"
    },
    {
      "affs": [
        1
      ],
      "name": "Yan-Dong Tang"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/aggv6ww5z1srd.bib",
  "cited_by": 0,
  "doi": "10.3389/fimmu.2026.1981961",
  "fulltext_url": "https://www.frontiersin.org/articles/10.3389/fimmu.2026.1981961/full",
  "id": "aggv6ww5z1srd",
  "issns": [
    "1664-3224"
  ],
  "landing_url": "https://www.frontiersin.org/articles/10.3389/fimmu.2026.1981961/full",
  "language": "en",
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC581-607"
    ],
    [
      "openalex",
      "2730|Cancer Immunotherapy and Biomarkers"
    ]
  ],
  "openalex": "W7224118336",
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-10-28",
  "publisher": "Frontiers Media SA",
  "ris": "https://research.draconitic.com/paper/aggv6ww5z1srd.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:19:17Z",
      "native_id": "10.3389/fimmu.2026.1981961",
      "source": "crossref",
      "url": "https://www.frontiersin.org/articles/10.3389/fimmu.2026.1981961/full"
    },
    {
      "first_seen": "2026-10-31T14:22:06Z",
      "native_id": "026d44aa75424191b01033ac09ce204e",
      "source": "doaj",
      "url": "https://doi.org/10.3389/fimmu.2026.1981961"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2730|Cancer Immunotherapy and Biomarkers",
      "subfield": "oncology"
    }
  ],
  "title": "Tumor tagging: making cold tumors visible to immunotherapy",
  "title_text": "Tumor tagging: making cold tumors visible to immunotherapy",
  "type": "peer-reviewed",
  "updated_at": "2026-10-31T14:22:06Z",
  "url": "https://research.draconitic.com/paper/aggv6ww5z1srd",
  "venue": "Frontiers in Immunology",
  "versions": []
}